Showing results (1681-1690 of 4,521) with videos related to

Sort By:
Pageof 453
Future Oncology (London, England)|October 30, 2025
Association of DDR pathway proteins and breast cancer risk in a Pakistani populationAzhar Mehmood, Ishrat Mahjabeen, Simon Reed, et al.
Future Oncology (London, England)|October 31, 2025
Embedding genetic testing in the metastatic prostate cancer pathway: understanding patient and physician perspectivesRuhee Jain, Amanda Ribbands, Jake Butcher, et al.
Future Oncology (London, England)|August 8, 2025
Access to treatment-guiding biomarkers in the UK: surveys of cancer patients and healthcare professionalsDany Bell, Rachel Bryce, Rosalia Delfino, et al.
Future Oncology (London, England)|August 7, 2025
Patterns of treatment in first and subsequent lines in RCC in Spain. A real-world descriptive cross-sectional studyJosé A Arranz, Cristina Martínez, Lucía Gallego, et al.
Future Oncology (London, England)|September 8, 2025
Disease management landscape in patients with mantle cell lymphoma in Japan: a real-world studyShinya Rai, Yoshinori Tanizawa, Tomoko Terasawa, et al.
Future Oncology (London, England)|September 15, 2025
Real-world safety and efficacy of trastuzumab deruxtecan (T-DXd) in patients with HER2-positive/HER2-low metastatic breast cancer: a multicenter retrospective cohort studyElias Kotteas, Εmmanouil Panagiotou, Μaria Grammoustianou, et al.
Future Oncology (London, England)|October 15, 2025
Knowledge, attitudes, and practices regarding HPV infection, cervical cancer, and HPV vaccination among Emirati womenSohazur Islam Sozib, Linda Smail, Ghufran A Jassim
Future Oncology (London, England)|August 5, 2025
State-level opportunities to advance biomarker testing in patients with advanced cancers and state-regulated plansWilliam B Wong, Tu My To
Future Oncology (London, England)|July 30, 2025
ESO-Shanghai 20: phase III clinical trial of anti-PD-1 therapy with local intervention for oligometastatic ESCCGuangmin Mao, Zhuocheng Xin, Qingsong Fan, et al.
Future Oncology (London, England)|July 28, 2025
Molecular testing, treatment patterns, and outcomes in EGFR-mutated non-small cell lung cancer: the PISCES studyPanwen Tian, Lin Wu, Chengzhi Zhou, et al.
Pageof 453